NAD Press Releases

NAD Recommends Boehringer Ingelheim Discontinue ‘Maximum Strength’ Claim for DulcoGas Product

The NAD has recommended Boehringer Ingelheim, maker of the anti-flatulence product “DulcoGas Maximum Strength,” discontinue “maximum strength” claims. The labeling claim was challenged by Novartis Consumer Health, Inc.

Read More

NAD Recommends Splintek Discontinue ‘#1 Brand Prescribed’ Claim, Bitepad Strength Claim for Dental Guards

NAD has recommended that the Splintek, Inc., the maker of SleepRight dental guards, discontinue “#1” brand prescribed claims and claims related to the strength of its products’ bitepads.

Read More

NAD Finds sBioMed Can Support Certain Claims for Hospital Disinfectant Steriplex SD, But Recommends Advertiser Modify, Discontinue Certain Claims

The NAD determined that sBiomed LLC, the maker of Steriplex SD disinfectant, can support certain claims for the product, but recommended the company discontinue references to “hospital studies” when claiming that Steriplex “kills the types of microorganisms” that can cause healthcare associated infections (HAIs.)

Read More

NAD Reviews Claims, Disclosures for P&G Duracell Rechargeable Batteries following Energizer Challenge

The NAD has determined that Procter & Gamble has taken necessary steps to modify and/or discontinue a “50% longer” advertising claim made on product packaging for the company’s Duracell Rechargeable Batteries.

Read More

NAD Examines Internet Speed Claims; Finds Comcast’s Monadic Speed Claim Supported But Recommends Modification to Better Disclose Limitations of Service; Recommends Discontinuation of Comparative Speed, Reliability Claims

NAD has recommended that Comcast Cable Communications, LLC, modify certain advertising claims made by the company for its “Extreme 505” high-speed Internet service, to better disclose the availability of the service.

Read More

NAD Examines Bayer Claims in Two Separate Alka-Seltzer Commercials; Finds Claims Supported in One Case, Recommends Discontinuance in Second Case

Following a review of broadcast advertising by Bayer Consumer Care, NAD has recommended that Bayer discontinue comparisons between its own Alka-Seltzer Plus Night Cold & Flu and The Procter & Gamble Company’s competing NyQuil Cold & Flu Liquid Gels.

Read More